Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs

Wilfred P. Dela Cruz, Joann Y. Richardson, Judith M. Broestler, Jennifer A. Thornton, Patrick J. Danaher

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Objective. Our objective was to assess the ability of real-time PCR to predict in vitro resistance in isolates of group B streptococcus (GBS). Methods. The first real-time PCR assays for the genes known to confer resistance to erythromycin and clindamycin in GBS were developed. Three hundred and forty clinical GBS isolates were assessed with these assays and compared with conventional disk diffusion. Results. The presence of an erythromycin ribosome methylation gene (ermB or ermTR variant A) predicted in vitro constitutive or inducible resistance to clindamycin with a sensitivity of 93% (95% CI 86%-97%), specificity of 90% (95% CI 85%-93%), positive predictive value of 76% (95% CI 67%-84%), and negative predictive value of 97% (95% CI 94%-99%). Conclusion. This rapid and simple assay can predict in vitro susceptibility to clindamycin within two hours of isolation as opposed to 18-24 hours via disk diffusion. The assay might also be used to screen large numbers of batched isolates to establish the prevalence of resistance in a given area.

Original languageEnglish (US)
Article number46581
JournalInfectious diseases in obstetrics and gynecology
Volume2007
DOIs
StatePublished - 2007

ASJC Scopus subject areas

  • Dermatology
  • Obstetrics and Gynecology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs'. Together they form a unique fingerprint.

Cite this